Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus.

Xie, Jing; Li, Ning; Jiang, Xiaoyan; Chai, Liyin; Chen, Jian-Jun; Deng, Wuquan

Xie, Jing; Li, Ning; Jiang, Xiaoyan; Chai, Liyin; Chen, Jian-Jun; Deng, Wuquan.

Afiliación

Xie J; Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People's Republic of China.
Li N; Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People's Republic of China.
Jiang X; Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People's Republic of China.
Chai L; Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People's Republic of China.
Chen JJ; Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, People's Republic of China.
Deng W; Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People's Republic of China.

Diabetes Metab Syndr Obes ; 12: 519-526, 2019.

Article en En | MEDLINE | ID: mdl-31114280

Palabras clave

diabetes; glimepiride; metformin; repaglinide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2019 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google